Disclosed is a compound of Formula II e.g. N-(4-((3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide and N-(4 ((3R,4R,5S)-3-amino-4-hydroxy-5-methylpiperidin-l-yl)pyridin-3-yl)-6-(2,6-dffluorophenyl)-5- fluoropicolinamide, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein the variables are defined in the specification for treating cancer.